Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018 - 2019)
Sunshine Biopharma (SBFM) posted Liabilities from Discontinued Operations of 103732.0 for Q2 2019, little changed on a QoQ basis from 103732.0 in Q1 2019.
Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018 - 2019) Analysis & Trends
Sunshine Biopharma's Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 103732.0 for Q2 2019.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 103732.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was 103732.0 (changed N/A YoY) and the FY2018 annual result came in at 103732.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations was 103732.0 for Q2 2019 at Sunshine Biopharma, roughly flat from 103732.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 103732.0 in Q4 2018 and bottomed at 103732.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 103,732.00 |
| Jun 30, 2019 | 103,732.00 |
| Mar 31, 2019 | 103,732.00 |
| Mar 31, 2019 | 103,732.00 |
| Dec 31, 2018 | 103,732.00 |
| Dec 31, 2018 | 103,732.00 |